Effect of 2 weeks of theophylline on glucose counterregulation in patients with type 1 diabetes and unawareness of hypoglycemia

Clinical Pharmacology and Therapeutics

Volumn 74, Issue 1, 2003, Pages 77-84

  De Galan, Bastiaan E ^a   Tack, Cees J ^a   Lenders, Jacques W ^a   Lutterman, Jos A ^a   Smits, Paul ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; NORADRENALIN; PLACEBO; THEOPHYLLINE;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERANCE; DRUG UTILIZATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GROWTH HORMONE BLOOD LEVEL; HEART RATE; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LONG TERM CARE; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; REGULATORY MECHANISM; SWEATING; SYMPTOM;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER CURVE; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIA; MALE; MIDDLE AGED; THEOPHYLLINE;

EID: 0037757969     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(03)00093-6     Document Type: Article

References (25)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. Cryer PE. Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM. Diabetes 1994;43:1378-89.
3. Kerr D, Sherwin RS, Pavalkis F, Fayad PB, Sikorski L, Rife F, et al. Effect of caffeine on the recognition of and responses to hypoglycemia in humans. Ann Intern Med 1993;119:799-804.
4. Debrah K, Sherwin RS, Murphy J, Kerr D. Effect of caffeine on recognition of and physiological responses to hypoglycaemia in insulin-dependent diabetes. Lancet 1996;347:19-24.
5. Hvidberg A, Rasmussen MH, Christensen NJ, Hilsted J. Theophylline enhances glucose recovery after hypoglycemia in healthy man and in type I diabetic patients. Metabolism 1994;43:776-81.
6. De Galan BE, Tack CJ, Lenders JW, Pasman JW, Elving LD, Russel FG, et al. Theophylline improves hypoglycemia unawareness in type 1 diabetes. Diabetes 2002;51:790-6.
7. Robertson D, Wade D, Workman R, Woosley RL, Oates JA. Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 1981;67:1111-7.
8. Hvidberg A, Rosenfalck A, Christensen NJ, Hilsted J. Long-term administration of theophylline and glucose recovery after hypoglycaemia in patients with type 1 diabetes mellitus. Diabet Med 1998;15:608-14.
9. Watson JM, Jenkins EJ, Hamilton P, Lunt MJ, Kerr D. Influence of caffeine on the frequency and perception of hypoglycemia in free-living patients with type 1 diabetes. Diabetes Care 2000;23:455-9.
10. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. BMJ 1982;285:916-8.
11. Hepburn DA, Deary IJ, Frier BM. Classification of symptoms of hypoglycaemia in insulin-treated diabetic patients using factor analysis: relationship to hypoglycaemia unawareness. Diabet Med 1992;9:70-5.
12. Davies AG, Evans S. Sweat detection as an indicator of nocturnal hypoglycaemia [Letter]. Lancet 1995;346:772.
13. Willemsen JJ, Ross HA, Jacobs MC, Lenders JW, Thien T, Swinkels LM, et al. Highly sensitive and specific HPLC with fluorometric detection for determination of plasma epinephrine and norepinephrine applied to kinetic studies in humans. Clin Chem 1995;41:1455-60.
14. Span JP, Pieters GF, Sweep CG, Swinkels LM, Smals AG. Plasma IGF-I is a useful marker of growth hormone deficiency in adults. J Endocrinol Invest 1999;22:446-50.
15. Fritsche A, Stefan N, Haring H, Gerich J, Stumvoll M. Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes. Ann Intern Med 2001;134:729-36.
16. Perlini S, Khoury EP, Norton GR, Chung ES, Fenton RA, Dobson JG Jr, et al. Adenosine mediates sustained adrenergic desensitization in the rat heart via activation of protein kinase C. Circ Res 1998;83:761-71.
17. De Feo P, Perriello G, Torlone E, Ventura MM, Santeusanio F, Brunetti P, et al. Demonstration of a role for growth hormone in glucose counterregulation. Am J Physiol 1989;256:E835-43.
18. MacGorman LR, Rizza RA, Gerich JE. Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man. J Clin Endocrinol Metab 1981;53:556-9.
19. Smits P, Pieters G, Thien T. The role of epinephrine in the circulatory effects of coffee. Clin Pharmacol Ther 1986;40:431-7.
20. Robertson D, Frolich JC, Carr RK, Watson JT, Hollifield JW, Shand DG, et al. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med 1978;298:181-6.
21. Grome JJ, Stefanovich V. Differential effects of methylxanthines on local cerebral blood flow and glucose utilization in the conscious rat. Naunyn Schmiedebergs Arch Pharmacol 1986;333:172-7.
22. Debrah K, Haigh R, Sherwin R, Murphy J, Kerr D. Effect of acute and chronic caffeine use on the cerebrovascular, cardiovascular and hormonal responses to orthostasis in healthy volunteers. Clin Sci (Lond) 1995;89:475-80.
23. Boyle PJ, Schwartz NS, Shah SD, Clutter WE, Cryer PE. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med 1988;318:1487-92.
24. Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, et al. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 1993;42:1683-9.
25. Cox D, Gonder Frederick L, Polonsky W, Schlundt D, Julian D, Clarke W. A multicenter evaluation of blood glucose awareness training. II. Diabetes Care 1995;18:523-8.